Lifespan, Dana-Farber Cancer Institute form alliance to further cancer treatment and research

LIFESPAN CEO Timothy Babineau said,
LIFESPAN CEO Timothy Babineau said, "We have submitted what we think is a very compelling, visionary and fair-minded proposal to Care New England." / COURTESY LIFESPAN
PROVIDENCE – The leadership of Lifespan and the Dana-Farber Cancer Institute, based in Boston, announced on Tuesday a new strategic alliance to advance cancer treatment and research. The alliance will support the expansion of shared clinical trials, offer Lifespan physicians access to Dana-Farber’s cancer-specific disease expertise for complex cancers and ensure that bone marrow transplant…

Want More?

Subscribe or register with Providence Business News to keep reading.

for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -

No posts to display